Method for treating a tuberculous prostatitis side effect caused by BCG perfusion therapy… Grant US-11324790-B2 United States of America 10 May 2022
TOPICAL COMPOSITION COMPRISING HYDROXAMIC ACID AND ATRACTYLENOLIDE Application WO-2021144326-A1 World Intellectual Property Organisation (WIPO) 22 Jul 2021